{
  "ticker": "JNJ",
  "key": "JNJ_Q1_2025",
  "year": 2025,
  "quarter": 1,
  "verified_at": "2026-02-13T17:39:35.619283",
  "claims_with_verdicts": [
    {
      "claim": {
        "metric_type": "revenue",
        "qualifiers": [],
        "confidence": 1,
        "comparison_period": "Q1 2024",
        "quote_start_char": 2749,
        "claimed_value_raw": "4.2%",
        "is_approximate": false,
        "speaker_role": "ceo",
        "claimed_value": 4.2,
        "quote_end_char": 2844,
        "scale": null,
        "claim_id": "claim_001",
        "unit": "percent",
        "claim_type": "yoy_growth",
        "metric_context": "Total",
        "quote_text": "In the first quarter, we delivered strong operational sales growth of 4.2% across our business.",
        "period": "Q1 2025",
        "gaap_classification": "non_gaap",
        "speaker": "Joaquin Duato"
      },
      "verification": {
        "claim_id": "claim_001",
        "claimed_value": 4.2,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "speaker": "Joaquin Duato",
        "gaap_classification": "non_gaap",
        "period": "Q1 2025",
        "quote_text": "In innovative medicine, we delivered 4.2% operational sales growth despite an approximate 810 basis points headwind from STELARA",
        "metric_context": "Innovative Medicine",
        "claim_type": "yoy_growth",
        "claim_id": "claim_002",
        "unit": "percent",
        "scale": null,
        "quote_end_char": 4026,
        "speaker_role": "ceo",
        "claimed_value": 4.2,
        "is_approximate": false,
        "claimed_value_raw": "4.2%",
        "comparison_period": "Q1 2024",
        "quote_start_char": 3898,
        "confidence": 1,
        "qualifiers": [],
        "metric_type": "revenue"
      },
      "verification": {
        "claim_id": "claim_002",
        "claimed_value": 4.2,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_end_char": 4174,
        "claimed_value": 3,
        "speaker_role": "ceo",
        "is_approximate": false,
        "claimed_value_raw": "$3 billion",
        "confidence": 1,
        "comparison_period": null,
        "quote_start_char": 4074,
        "qualifiers": [
          "above"
        ],
        "metric_type": "revenue",
        "speaker": "Joaquin Duato",
        "period": "Q1 2025",
        "quote_text": "With our third consecutive quarter of sales above $3 billion, DARZALEX continues to set the standard",
        "gaap_classification": "gaap",
        "metric_context": "DARZALEX",
        "claim_type": "absolute",
        "unit": "dollars",
        "claim_id": "claim_003",
        "scale": "billions"
      },
      "verification": {
        "claim_id": "claim_003",
        "claimed_value": 3,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a DARZALEX revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [
          "over"
        ],
        "confidence": 1,
        "comparison_period": "Q1 2024",
        "quote_start_char": 4195,
        "metric_type": "revenue",
        "speaker_role": "ceo",
        "claimed_value": 20,
        "quote_end_char": 4235,
        "claimed_value_raw": "20%",
        "is_approximate": false,
        "claim_type": "yoy_growth",
        "scale": null,
        "claim_id": "claim_004",
        "unit": "percent",
        "speaker": "Joaquin Duato",
        "metric_context": "DARZALEX",
        "quote_text": "with another quarter of over 20% growth.",
        "period": "Q1 2025",
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_004",
        "claimed_value": 20,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a DARZALEX revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_type": "yoy_growth",
        "scale": null,
        "unit": "percent",
        "claim_id": "claim_005",
        "speaker": "Joaquin Duato",
        "metric_context": "Tremfya",
        "gaap_classification": "non_gaap",
        "period": "Q1 2025",
        "quote_text": "launch in ulcerative colitis helping accelerate operational sales growth to 20%.",
        "qualifiers": [],
        "comparison_period": "Q1 2024",
        "quote_start_char": 5419,
        "confidence": 1,
        "metric_type": "revenue",
        "claimed_value": 20,
        "speaker_role": "ceo",
        "quote_end_char": 5499,
        "claimed_value_raw": "20%",
        "is_approximate": false
      },
      "verification": {
        "claim_id": "claim_005",
        "claimed_value": 20,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_type": "yoy_growth",
        "claim_id": "claim_006",
        "unit": "percent",
        "scale": null,
        "speaker": "Joaquin Duato",
        "gaap_classification": "non_gaap",
        "quote_text": "Turning to MedTech, in Q1, we delivered 4.1% operational sales growth with strong performance",
        "period": "Q1 2025",
        "metric_context": "MedTech",
        "comparison_period": "Q1 2024",
        "quote_start_char": 5688,
        "confidence": 1,
        "qualifiers": [],
        "metric_type": "revenue",
        "quote_end_char": 5781,
        "speaker_role": "ceo",
        "claimed_value": 4.1,
        "is_approximate": false,
        "claimed_value_raw": "4.1%"
      },
      "verification": {
        "claim_id": "claim_006",
        "claimed_value": 4.1,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_type": "revenue",
        "confidence": 1,
        "comparison_period": null,
        "quote_start_char": 14174,
        "qualifiers": [],
        "is_approximate": false,
        "claimed_value_raw": "$21.9 billion",
        "quote_end_char": 14245,
        "speaker_role": "management",
        "claimed_value": 21.9,
        "claim_id": "claim_007",
        "unit": "dollars",
        "scale": "billions",
        "claim_type": "absolute",
        "period": "Q1 2025",
        "quote_text": "Starting with Q1 2025 sales results, worldwide sales were $21.9 billion",
        "gaap_classification": "gaap",
        "metric_context": "Total",
        "speaker": "Jessica Moore"
      },
      "verification": {
        "claim_id": "claim_007",
        "claimed_value": 21.9,
        "actual_value": 21893000000,
        "difference": 7000000.0,
        "difference_pct": 0.03197369022061847,
        "tolerance_used": 0.005,
        "computation_detail": "Claimed 21,900,000,000.00 vs Actual 21,893,000,000.00. Diff: 0.03% (threshold: 0.5%)",
        "computation_steps": [
          {
            "step": "Absolute comparison",
            "formula": "|21,900,000,000.00 - 21,893,000,000.00| / |21,893,000,000.00|",
            "result": 0.00031973690220618464,
            "threshold": 0.005
          }
        ],
        "financial_facts_used": [
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 1,
            "value": 21893000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed 21,900,000,000.00 vs actual 21,893,000,000.00 from fmp.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "claim_id": "claim_008",
        "unit": "dollars",
        "scale": "billions",
        "claim_type": "absolute",
        "gaap_classification": "gaap",
        "quote_text": "Turning now to earnings, for the quarter, net earnings were $11 billion",
        "period": "Q1 2025",
        "metric_context": "Total",
        "speaker": "Jessica Moore",
        "metric_type": "net_income",
        "comparison_period": null,
        "quote_start_char": 14462,
        "confidence": 1,
        "qualifiers": [],
        "is_approximate": false,
        "claimed_value_raw": "$11 billion",
        "quote_end_char": 14533,
        "claimed_value": 11,
        "speaker_role": "management"
      },
      "verification": {
        "claim_id": "claim_008",
        "claimed_value": 11,
        "actual_value": 10999000000,
        "difference": 1000000,
        "difference_pct": 0.009091735612328393,
        "tolerance_used": 0.01,
        "computation_detail": "Claimed 11,000,000,000.00 vs Actual 10,999,000,000.00. Diff: 0.01% (threshold: 1.0%)",
        "computation_steps": [
          {
            "step": "Absolute comparison",
            "formula": "|11,000,000,000.00 - 10,999,000,000.00| / |10,999,000,000.00|",
            "result": 9.091735612328394e-05,
            "threshold": 0.01
          }
        ],
        "financial_facts_used": [
          {
            "field": "net_income",
            "fy": 2025,
            "fq": 1,
            "value": 10999000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed 11,000,000,000.00 vs actual 10,999,000,000.00 from fmp.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "confidence": 1,
        "comparison_period": null,
        "quote_start_char": 14538,
        "qualifiers": [],
        "metric_type": "eps_diluted",
        "quote_end_char": 14628,
        "claimed_value": 4.54,
        "speaker_role": "management",
        "is_approximate": false,
        "claimed_value_raw": "$4.54",
        "claim_type": "absolute",
        "unit": "per_share",
        "claim_id": "claim_009",
        "scale": null,
        "speaker": "Jessica Moore",
        "period": "Q1 2025",
        "quote_text": "diluted earnings per share was $4.54 versus diluted earnings per share of $1.34 a year ago",
        "gaap_classification": "gaap",
        "metric_context": "Total"
      },
      "verification": {
        "claim_id": "claim_009",
        "claimed_value": 4.54,
        "actual_value": 4.54,
        "difference": 0.0,
        "difference_pct": 0.0,
        "tolerance_used": 0.005,
        "computation_detail": "EPS: claimed $4.54 vs actual $4.54. Diff $0.000 within $0.005 tolerance.",
        "computation_steps": [
          {
            "step": "EPS absolute comparison",
            "formula": "|4.54 - 4.54| = 0.000",
            "result": 0.0,
            "threshold": 0.005
          }
        ],
        "financial_facts_used": [
          {
            "field": "eps_diluted",
            "fy": 2025,
            "fq": 1,
            "value": 4.54
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed $4.54 matches actual $4.54.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "claim_type": "absolute",
        "claim_id": "claim_010",
        "unit": "dollars",
        "scale": "billions",
        "speaker": "Jessica Moore",
        "gaap_classification": "non_gaap",
        "quote_text": "Excluding after-tax intangible and special items for both periods, adjusted net earnings for the quarter were $6.7 billion",
        "period": "Q1 2025",
        "metric_context": "Total",
        "comparison_period": null,
        "quote_start_char": 14718,
        "confidence": 1,
        "qualifiers": [],
        "metric_type": "net_income",
        "quote_end_char": 14840,
        "claimed_value": 6.7,
        "speaker_role": "management",
        "is_approximate": false,
        "claimed_value_raw": "$6.7 billion"
      },
      "verification": {
        "claim_id": "claim_010",
        "claimed_value": 6.7,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_type": "absolute",
        "scale": null,
        "claim_id": "claim_011",
        "unit": "per_share",
        "speaker": "Jessica Moore",
        "metric_context": "Total",
        "gaap_classification": "non_gaap",
        "quote_text": "adjusted diluted earnings per share was $2.77, representing increases of 1.9% and 2.2% respectively compared to the first quarter of 2024.",
        "period": "Q1 2025",
        "qualifiers": [],
        "quote_start_char": 14845,
        "comparison_period": null,
        "confidence": 1,
        "metric_type": "eps_diluted",
        "claimed_value": 2.77,
        "speaker_role": "management",
        "quote_end_char": 14983,
        "claimed_value_raw": "$2.77",
        "is_approximate": false
      },
      "verification": {
        "claim_id": "claim_011",
        "claimed_value": 2.77,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [],
        "confidence": 1,
        "comparison_period": null,
        "quote_start_char": 15186,
        "metric_type": "revenue",
        "claimed_value": 13.9,
        "speaker_role": "management",
        "quote_end_char": 15269,
        "claimed_value_raw": "$13.9 billion",
        "is_approximate": false,
        "claim_type": "absolute",
        "scale": "billions",
        "claim_id": "claim_012",
        "unit": "dollars",
        "speaker": "Jessica Moore",
        "metric_context": "Innovative Medicine",
        "quote_text": "Beginning with innovative medicine, worldwide sales of $13.9 billion increased 4.2%",
        "period": "Q1 2025",
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_012",
        "claimed_value": 13.9,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a Innovative Medicine revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_type": "revenue",
        "confidence": 1,
        "comparison_period": "Q1 2024",
        "quote_start_char": 15390,
        "qualifiers": [],
        "is_approximate": false,
        "claimed_value_raw": "22.5%",
        "quote_end_char": 15435,
        "speaker_role": "management",
        "claimed_value": 22.5,
        "claim_id": "claim_013",
        "unit": "percent",
        "scale": null,
        "claim_type": "yoy_growth",
        "period": "Q1 2025",
        "quote_text": "Starting with oncology, SARS growth was 22.5%",
        "gaap_classification": "gaap",
        "metric_context": "Oncology",
        "speaker": "Jessica Moore"
      },
      "verification": {
        "claim_id": "claim_013",
        "claimed_value": 22.5,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a Oncology revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_id": "claim_014",
        "unit": "dollars",
        "scale": "millions",
        "claim_type": "absolute",
        "gaap_classification": "gaap",
        "period": "Q1 2025",
        "quote_text": "Pervixi achieved sales of $369 million and growth of over 100%",
        "metric_context": "CARVYKTI",
        "speaker": "Jessica Moore",
        "metric_type": "revenue",
        "comparison_period": null,
        "quote_start_char": 15618,
        "confidence": 1,
        "qualifiers": [],
        "is_approximate": false,
        "claimed_value_raw": "$369 million",
        "quote_end_char": 15680,
        "speaker_role": "management",
        "claimed_value": 369
      },
      "verification": {
        "claim_id": "claim_014",
        "claimed_value": 369,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a CARVYKTI revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "scale": null,
        "unit": "percent",
        "claim_id": "claim_015",
        "claim_type": "yoy_growth",
        "metric_context": "STELARA",
        "gaap_classification": "gaap",
        "quote_text": "STELARA declined 32.3%",
        "period": "Q1 2025",
        "speaker": "Jessica Moore",
        "metric_type": "revenue",
        "qualifiers": [],
        "quote_start_char": 16495,
        "comparison_period": "Q1 2024",
        "confidence": 1,
        "claimed_value_raw": "32.3%",
        "is_approximate": false,
        "claimed_value": 32.3,
        "speaker_role": "management",
        "quote_end_char": 16517
      },
      "verification": {
        "claim_id": "claim_015",
        "claimed_value": 32.3,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a STELARA revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "scale": "billions",
        "claim_id": "claim_016",
        "unit": "dollars",
        "claim_type": "absolute",
        "metric_context": "MedTech",
        "gaap_classification": "gaap",
        "period": "Q1 2025",
        "quote_text": "Turning now to MedTech. Worldwide sales of $8 billion increased 4.1%",
        "speaker": "Jessica Moore",
        "metric_type": "revenue",
        "qualifiers": [],
        "comparison_period": null,
        "quote_start_char": null,
        "confidence": 1,
        "claimed_value_raw": "$8 billion",
        "is_approximate": false,
        "claimed_value": 8,
        "speaker_role": "management",
        "quote_end_char": null
      },
      "verification": {
        "claim_id": "claim_016",
        "claimed_value": 8,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a MedTech revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_type": "free_cash_flow",
        "qualifiers": [
          "approximately"
        ],
        "confidence": 1,
        "quote_start_char": 24833,
        "comparison_period": null,
        "claimed_value_raw": "$3.4 billion",
        "is_approximate": true,
        "claimed_value": 3.4,
        "speaker_role": "cfo",
        "quote_end_char": 24917,
        "scale": "billions",
        "unit": "dollars",
        "claim_id": "claim_017",
        "claim_type": "absolute",
        "metric_context": "Total",
        "period": "Q1 2025",
        "quote_text": "pleased with free cash flow generation in the quarter of approximately $3.4 billion.",
        "gaap_classification": "unknown",
        "speaker": "Joe Wolk"
      },
      "verification": {
        "claim_id": "claim_017",
        "claimed_value": 3.4,
        "actual_value": 3365000000,
        "difference": 35000000.0,
        "difference_pct": 1.040118870728083,
        "tolerance_used": 0.1,
        "computation_detail": "Claimed 3,400,000,000.00 vs Actual 3,365,000,000.00. Diff: 1.04% (threshold: 10.0%)",
        "computation_steps": [
          {
            "step": "Absolute comparison",
            "formula": "|3,400,000,000.00 - 3,365,000,000.00| / |3,365,000,000.00|",
            "result": 0.010401188707280832,
            "threshold": 0.1
          }
        ],
        "financial_facts_used": [
          {
            "field": "free_cash_flow",
            "fy": 2025,
            "fq": 1,
            "value": 3365000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed 3,400,000,000.00 vs actual 3,365,000,000.00 from fmp.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "claim_type": "absolute",
        "scale": "billions",
        "unit": "dollars",
        "claim_id": "claim_018",
        "speaker": "Joe Wolk",
        "metric_context": "Total",
        "period": "Q1 2025",
        "quote_text": "during the first quarter, we invested more than $3 billion in research and development, approximately 15% of sales.",
        "gaap_classification": "gaap",
        "qualifiers": [
          "more than"
        ],
        "confidence": 1,
        "quote_start_char": 25431,
        "comparison_period": null,
        "metric_type": "research_and_development",
        "speaker_role": "cfo",
        "claimed_value": 3,
        "quote_end_char": 25546,
        "claimed_value_raw": "$3 billion",
        "is_approximate": false
      },
      "verification": {
        "claim_id": "claim_018",
        "claimed_value": 3,
        "actual_value": 3225000000,
        "difference": -225000000,
        "difference_pct": 6.976744186046512,
        "tolerance_used": 0.01,
        "computation_detail": "Claimed 3,000,000,000.00 vs Actual 3,225,000,000.00. Diff: 6.98% (threshold: 1.0%)",
        "computation_steps": [
          {
            "step": "Absolute comparison",
            "formula": "|3,000,000,000.00 - 3,225,000,000.00| / |3,225,000,000.00|",
            "result": 0.06976744186046512,
            "threshold": 0.01
          }
        ],
        "financial_facts_used": [
          {
            "field": "research_and_development",
            "fy": 2025,
            "fq": 1,
            "value": 3225000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Mismatch: claimed 3,000,000,000.00 vs actual 3,225,000,000.00 from fmp.",
        "verdict": "mismatch"
      }
    },
    {
      "claim": {
        "metric_type": "revenue",
        "qualifiers": [],
        "quote_start_char": 26640,
        "comparison_period": "FY 2024",
        "confidence": 1,
        "claimed_value_raw": "3.8%",
        "is_approximate": false,
        "speaker_role": "cfo",
        "claimed_value": 3.8,
        "quote_end_char": 26771,
        "scale": null,
        "claim_id": "claim_019",
        "unit": "percent",
        "claim_type": "guidance",
        "metric_context": "Total",
        "gaap_classification": "non_gaap",
        "period": "FY 2025",
        "quote_text": "we now expect operational sales growth for the full year to be in the range of 3.3% to 4.3% with a midpoint of $92 billion or 3.8%.",
        "speaker": "Joe Wolk"
      },
      "verification": {
        "claim_id": "claim_019",
        "claimed_value": 3.8,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "unit": "per_share",
        "claim_id": "claim_020",
        "scale": null,
        "claim_type": "guidance",
        "period": "FY 2025",
        "quote_text": "based on what is in place today, we are pleased to be able to maintain our adjusted reported earnings per share guidance of 6.2% at the midpoint for a range of $10.50 to $10.70, partially aided by the reduced FX impact.",
        "gaap_classification": "non_gaap",
        "metric_context": "Total",
        "speaker": "Joe Wolk",
        "metric_type": "eps_diluted",
        "confidence": 1,
        "comparison_period": null,
        "quote_start_char": 28089,
        "qualifiers": [],
        "is_approximate": false,
        "claimed_value_raw": "$10.60",
        "quote_end_char": 28308,
        "claimed_value": 10.6,
        "speaker_role": "cfo"
      },
      "verification": {
        "claim_id": "claim_020",
        "claimed_value": 10.6,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    }
  ],
  "summary": {
    "total": 20,
    "verified": 4,
    "close_match": 0,
    "mismatch": 1,
    "misleading": 0,
    "unverifiable": 15
  }
}